Condition: Normal Pregnancy · Sponsor: Assistance Publique - Hôpitaux de Paris
Drug prescriptions are usual during pregnancy however women and their fetuses still remain an orphan population with regard to drugs efficacy and safety clinical studies. Most xenobiotics diffuse through the placenta and some of them can alter fetus development resulting in structural abnormalities, growth or functional deficiencies. The aim of the study is to study the drug transfer using human placenta after delivery.
This description comes directly from the study's public registry record.
Jean-Marc TRELUYER, Pr · 00 33 1 58 41 28 85 · jean-marc.treluyer@parisdescartes.fr
Marie BENHAMMANI-GODARD · 00 33 1 54 41 12 11 · marie.godard@aphp.fr
Always discuss trial participation with your own doctor first.
| CIC Port-Royal-Cochin | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04400084